CASP1 and obesity due to melanocortin 4 receptor deficiency: Under dyslipidemic and inflammatory conditions such as hyperlipidemia, hypercholesterolemia, or obesity, caspase-1 activation leads to the upregulation of the inflammasome pathway, activated by elevated lipids or inflammatory mediators, such as DAMPs, in ECs [5,12].